Polar NanoPharma
PrivateLast Round
Grant
May 27, 2026
Total Funding Raised
$21,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Polar NanoPharma operates in Healthcare & Life Sciences and is based in Spain. Its latest recorded funding round was a Grant round in May 2026.
Polar NanoPharma is a biotechnology company that develops advanced nanoparticle-based drug delivery systems for oncology applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Polar NanoPharma Comparables
Compare Polar NanoPharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libera Bio | 87% | |
| QurCan Therapeutics | 83% | |
| InnoUp Farma | 77% |
For institutional investors. Book with your work email.
Polar NanoPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 27, 2026 | ||||
| Pre Seed | Jan 1, 2026 | ||||
| Accelerator | Feb 20, 2025 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 192% MoM, reaching 587.
- May 27, 2026
$21K grant received from EmprendeXXI Awards and Spanish Chamber of Commerce.
For institutional investors. Book with your work email.
Polar NanoPharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Polar NanoPharma's valuation, stock price, and market status.
Is Polar NanoPharma a public or private company?
Polar NanoPharma is a private company.
What is the current stock price of Polar NanoPharma?
Polar NanoPharma is a private company, so its shares have no public market price. Caplight tracks Polar NanoPharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Polar NanoPharma worth (valuation)?
Valuation information for Polar NanoPharma is not publicly available.
Can I buy Polar NanoPharma stock?
Polar NanoPharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Polar NanoPharma's last funding round?
Polar NanoPharma's most recent funding round was Grant on May 27, 2026.
Who are the main investors in Polar NanoPharma?
Investor information for Polar NanoPharma is not publicly disclosed.
Will Polar NanoPharma IPO soon?
No public IPO plans have been announced for Polar NanoPharma.
How can I track Polar NanoPharma secondary market activity?
Caplight tracks bids, offers, and trades in Polar NanoPharma's shares on secondary markets.